Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Andre C Kalil

Showing results (21-30 of 277) with videos related to

Pageof 28
Sort By:
Current Opinion in Critical Care|September 9, 2024
Patients with severe infections: how to improve their clinical management?Andre C Kalil
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|April 13, 2005
The use of dexamethasone in bacterial meningitisAndre C Kalil
Critical Care Medicine|August 19, 2017
Antibiotic Combination Therapy for Patients With Gram-Negative Septic ShockAndre C Kalil
The New England Journal of Medicine|December 21, 2004
New drugs for rheumatoid arthritisAndre C Kalil
JAMA|August 12, 2020
Need for Additional Trials of Vitamin C for Sepsis-ReplyAndre C Kalil
JAMA Network Open|January 16, 2019
Toward a More Nuanced Approach to the Early Administration of Intravenous Fluids in Patients With SepsisChanu Rhee, Andre C Kalil
The Lancet. Infectious Diseases|December 20, 2017
Ceftazidime-avibactam versus meropenem for the treatment of nosocomial pneumoniaAndre C Kalil, Michael Klompas
Plos One|May 30, 2008
Why are clinicians not embracing the results from pivotal clinical trials in severe sepsis? A bayesian analysisAndre C Kalil, Junfeng Sun
The Lancet. Respiratory Medicine|September 15, 2022
Complement C5a inhibition: a new form of COVID-19 treatment for mechanically ventilated patients?Andre C Kalil, Michael Proschan
The Lancet. Respiratory Medicine|September 4, 2021
Baricitinib: the first immunomodulatory treatment to reduce COVID-19 mortality in a placebo-controlled trialAndre C Kalil, Justin Stebbing
Pageof 28

Showing results (21-30 of 277) with videos related to

Sort By:
Pageof 28
Current Opinion in Critical Care|September 9, 2024
Patients with severe infections: how to improve their clinical management?Andre C Kalil
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|April 13, 2005
The use of dexamethasone in bacterial meningitisAndre C Kalil
Critical Care Medicine|August 19, 2017
Antibiotic Combination Therapy for Patients With Gram-Negative Septic ShockAndre C Kalil
The New England Journal of Medicine|December 21, 2004
New drugs for rheumatoid arthritisAndre C Kalil
JAMA|August 12, 2020
Need for Additional Trials of Vitamin C for Sepsis-ReplyAndre C Kalil
JAMA Network Open|January 16, 2019
Toward a More Nuanced Approach to the Early Administration of Intravenous Fluids in Patients With SepsisChanu Rhee, Andre C Kalil
The Lancet. Infectious Diseases|December 20, 2017
Ceftazidime-avibactam versus meropenem for the treatment of nosocomial pneumoniaAndre C Kalil, Michael Klompas
Plos One|May 30, 2008
Why are clinicians not embracing the results from pivotal clinical trials in severe sepsis? A bayesian analysisAndre C Kalil, Junfeng Sun
The Lancet. Respiratory Medicine|September 15, 2022
Complement C5a inhibition: a new form of COVID-19 treatment for mechanically ventilated patients?Andre C Kalil, Michael Proschan
The Lancet. Respiratory Medicine|September 4, 2021
Baricitinib: the first immunomodulatory treatment to reduce COVID-19 mortality in a placebo-controlled trialAndre C Kalil, Justin Stebbing
Pageof 28